BioCentury
ARTICLE | Finance

Out of sequence

Complete Genomics breaks IPO price; Ikaria, Rules-Based Medicine pull deals

November 15, 2010 8:00 AM UTC

Complete Genomics Inc. (NASDAQ:GNOM) didn't fare quite as well with its IPO last week as fellow genome sequencing play Pacific Biosciences Inc. (NASDAQ:PACB) did late last month.

Complete Genomics priced at $9, well below its $12-$14 range and traded down $0.97 (11%) to $8.03 in its first day of trading on Thursday. It then fell on Friday to finish the week down $1.31 (15%) at $7.69...